Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
published in: The Lancet
date of publication: 2002-04-01
language: English
main subject: multicenter clinical trial, multiple sclerosis
Cites articles 23
- 2001-07-01
Date
Title
Article - wd:Q40583199